Subspecialty-Specific Foundation Model for Intelligent Gastrointestinal Pathology

📅 2025-05-28
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Gastrointestinal (GI) pathology diagnosis suffers from high subjectivity, low reproducibility, and a lack of specialized AI models. To address these challenges, we propose Digepath—the first subspecialty foundation model for GI pathology—introduced with a novel two-stage iterative optimization framework: self-supervised pretraining followed by curated fine-tuning, specifically designed for sparse lesion detection. Pretrained on 353 million H&E image patches, Digepath integrates multi-task fine-tuning, resolution-agnostic tissue classification, and an intelligent early-cancer screening module. It is the first model to unify diagnosis, molecular phenotyping, somatic mutation inference, and prognostic assessment within a single architecture. Evaluated across 34 GI pathology tasks, Digepath achieves state-of-the-art performance on 33. In multicenter validation across nine hospitals, it attains 99.6% sensitivity for early gastric cancer detection and significantly improves diagnostic consistency and accuracy for challenging cases.

Technology Category

Application Category

📝 Abstract
Gastrointestinal (GI) diseases represent a clinically significant burden, necessitating precise diagnostic approaches to optimize patient outcomes. Conventional histopathological diagnosis, heavily reliant on the subjective interpretation of pathologists, suffers from limited reproducibility and diagnostic variability. To overcome these limitations and address the lack of pathology-specific foundation models for GI diseases, we develop Digepath, a specialized foundation model for GI pathology. Our framework introduces a dual-phase iterative optimization strategy combining pretraining with fine-screening, specifically designed to address the detection of sparsely distributed lesion areas in whole-slide images. Digepath is pretrained on more than 353 million image patches from over 200,000 hematoxylin and eosin-stained slides of GI diseases. It attains state-of-the-art performance on 33 out of 34 tasks related to GI pathology, including pathological diagnosis, molecular prediction, gene mutation prediction, and prognosis evaluation, particularly in diagnostically ambiguous cases and resolution-agnostic tissue classification.We further translate the intelligent screening module for early GI cancer and achieve near-perfect 99.6% sensitivity across 9 independent medical institutions nationwide. The outstanding performance of Digepath highlights its potential to bridge critical gaps in histopathological practice. This work not only advances AI-driven precision pathology for GI diseases but also establishes a transferable paradigm for other pathology subspecialties.
Problem

Research questions and friction points this paper is trying to address.

Develops a specialized AI model for gastrointestinal pathology diagnosis
Addresses variability in histopathological diagnosis with deep learning
Enhances early cancer detection accuracy across multiple institutions
Innovation

Methods, ideas, or system contributions that make the work stand out.

Dual-phase iterative optimization strategy
Pretrained on 353 million GI image patches
99.6% sensitivity in early cancer screening
🔎 Similar Papers
No similar papers found.
L
Lianghui Zhu
Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Shenzhen, Guangdong, China.
Xitong Ling
Xitong Ling
Tsinghua University
AI4PathologyFoundation-ModelVision-Language-Model
Minxi Ouyang
Minxi Ouyang
Tsinghua University
cvpathology
X
Xiaoping Liu
Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China.
M
Mingxi Fu
Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Shenzhen, Guangdong, China.
T
Tian Guan
Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Shenzhen, Guangdong, China.
F
Fanglei Fu
Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Shenzhen, Guangdong, China.
X
Xuanyu Wang
Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China.
M
Maomao Zeng
Shenzhen Zhengjingda Instrument Co., Ltd., Shenzhen, Guangdong, China.
M
Mingxi Zhu
Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Shenzhen, Guangdong, China.
Yibo Jin
Yibo Jin
State Key Lab. for Novel Software Technol., Nanjing Univ., Nanjing, China
Distributed SystemMachine Learning
L
Liming Liu
Department of Pathology, the Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China.
S
Song Duan
Department of Pathology, Chongqing University Affiliated Three Gorges Hospital, Chongqing, China.
Qiming He
Qiming He
CRRC Times Semiconductor Inc.
Y
Yizhi Wang
Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Shenzhen, Guangdong, China.
L
Luxi Xie
Department of Pathology, Liuzhou People's Hospital Affiliated to Guangxi Medical University, Liuzhou, Guangxi, China.
Houqiang Li
Houqiang Li
Professor, Department of Electric Engineering and Information Science, University of Science and
Multimedia SearchImage/Video AnalysisImage/Video Coding
Yonghong He
Yonghong He
清华大学深圳国际研究生院
生物医学工程,光学成像,AI图像处理、病理大模型
S
Sufang Tian
Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China.